[Click eStock] "GenieN Expected to Improve Earnings in Q4"

Eugene Investment & Securities predicted on November 20 that GenieN's performance in the fourth quarter of this year will increase compared to the previous year.

The company estimated that GenieN will achieve sales of 23.3 billion won and an operating profit of 7.4 billion won in the fourth quarter of this year. This represents an increase of 14.3% and 19.1%, respectively, compared to the same period last year.

Park Jongsun, a researcher at Eugene Investment & Securities, explained, "The reason for expecting improved performance is that the government's 'Comprehensive Inter-Ministerial Information Security Plan' will lead to the establishment of a national cyber security strategy within this year."

He added, "GenieN has launched the 'Genian Insight E' product, which integrates vaccine solutions," and noted, "Since it can be tailored to corporate needs, we expect it to benefit from this." He also emphasized, "The company is continuing to expand overseas, leveraging its U.S. subsidiary, Middle East office, and global customer center in India."

Researcher Park analyzed, "A positive aspect of the third quarter's performance is the increased demand for NAC products from large manufacturing companies and SMBs," and added, "The launch of vaccine products, which enabled the implementation of an endpoint device platform, is also a factor for growth expectations." He further explained, "Securing the first customer for the MDR service, which provides EDR services, is also positive," and noted, "The company has surpassed a cumulative total of 180 global customers."

원본보기 아이콘

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.